CAS 112-80-1|oleic acid
| Common Name | oleic acid | ||
|---|---|---|---|
| CAS Number | 112-80-1 | Molecular Weight | 282.461 |
| Density | 0.9±0.1 g/cm3 | Boiling Point | 360.0±0.0 °C at 760 mmHg |
| Molecular Formula | C18H34O2 | Melting Point | 13-14 °C(lit.) |
| MSDS | ChineseUSA | Flash Point | 270.1±14.4 °C |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | oleic acid |
|---|---|
| Synonym | More Synonyms |
oleic acid BiologicalActivity
| Description | Oleic acid is an abundant monounsaturated fatty acid. |
|---|---|
| Related Catalog | Natural Products >>Acids and AldehydesResearch Areas >>Others |
| Target | Human Endogenous Metabolite |
| In Vitro | Oleic acid is the most common monounsaturated fatty acids (FA) in human adipocytes and other tissues. Oleic acid prompts cell proliferation and migration in high metastatic cancer cells via enhancing β-oxidation mediated by AMPK activation. Oleic acid inhibits cancer cell growth and survival in low metastatic carcinoma cells, such as gastric carcinoma SGC7901 and breast carcinoma MCF-7 cell lines[1]. |
| References | [1]. Li S, et al. High metastaticgastric and breast cancer cells consume oleic acid in an AMPK dependent manner. PLoS One. 2014 May 13;9(5):e97330. |
Chemical & Physical Properties
| Density | 0.9±0.1 g/cm3 |
|---|---|
| Boiling Point | 360.0±0.0 °C at 760 mmHg |
| Melting Point | 13-14 °C(lit.) |
| Molecular Formula | C18H34O2 |
| Molecular Weight | 282.461 |
| Flash Point | 270.1±14.4 °C |
| Exact Mass | 282.255890 |
| PSA | 37.30000 |
| LogP | 7.70 |
| Vapour density | 1.03 (vs air) |
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
| Index of Refraction | 1.467 |
| InChIKey | ZQPPMHVWECSIRJ-KTKRTIGZSA-N |
| SMILES | CCCCCCCCC=CCCCCCCCC(=O)O |
| Storage condition | 2-8°C |
| Stability | Stable. Combustible. Incompatible with strong oxidizing agents, aluminium. |
| Water Solubility | negligible |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- Standard Draize test
- ROUTE OF EXPOSURE :
- Administration onto the skin
- SPECIES OBSERVED :
- Human
- TYPE OF TEST :
- Open irritation test
- ROUTE OF EXPOSURE :
- Administration onto the skin
- SPECIES OBSERVED :
- Rodent - rabbit
- TYPE OF TEST :
- Standard Draize test
- ROUTE OF EXPOSURE :
- Administration into the eye
- SPECIES OBSERVED :
- Rodent - rabbit
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 74 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 2400 ug/kg
- TOXIC EFFECTS :
- Lungs, Thorax, or Respiration - acute pulmonary edema Lungs, Thorax, or Respiration - other changes
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 282 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 230 mg/kg
- TOXIC EFFECTS :
- Behavioral - convulsions or effect on seizure threshold
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rabbit
- DOSE/DURATION :
- 390 mg/kg/17W-I
- TOXIC EFFECTS :
- Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - tumors at site of application
- TYPE OF TEST :
- Unscheduled DNA synthesis
MUTATION DATA - TYPE OF TEST :
- Cytogenetic analysis
- TEST SYSTEM :
- Rodent - hamster Fibroblast
- DOSE/DURATION :
- 2500 ug/L
- REFERENCE :
- CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- Volume(issue)/page/year: 3,499,1982 *** U.S. STANDARDS AND REGULATIONS *** EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION FEREAC Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- Volume(issue)/page/year: 54,7740,1989 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 52190 No. of Facilities: 65952 (estimated) No. of Industries: 312 No. of Occupations: 196 No. of Employees: 796897 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 52190 No. of Facilities: 49332 (estimated) No. of Industries: 256 No. of Occupations: 181 No. of Employees: 1078478 (estimated) No. of Female Employees: 410362 (estimated)
- TYPE OF TEST :
- Cytogenetic analysis
- TEST SYSTEM :
- Rodent - hamster Fibroblast
- DOSE/DURATION :
- 2500 ug/L
- REFERENCE :
- CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- Volume(issue)/page/year: 3,499,1982 *** U.S. STANDARDS AND REGULATIONS *** EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION FEREAC Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- Volume(issue)/page/year: 54,7740,1989 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 52190 No. of Facilities: 65952 (estimated) No. of Industries: 312 No. of Occupations: 196 No. of Employees: 796897 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 52190 No. of Facilities: 49332 (estimated) No. of Industries: 256 No. of Occupations: 181 No. of Employees: 1078478 (estimated) No. of Female Employees: 410362 (estimated)
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315 |
| Personal Protective Equipment | Eyeshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | Xi:Irritant |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S36/37-S37/39-S26-S36 |
| RIDADR | UN 1198 3/PG 3 |
| WGK Germany | 2 |
| RTECS | LP8925000 |
| HS Code | 2916150000 |
Customs
| HS Code | 2916150000 |
|---|---|
| Summary | 2916150000 oleic, linoleic or linolenic acids, their salts and esters。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0% |
Articles544
More Articles| Differential expression of efflux pump genes of Mycobacterium tuberculosis in response to varied subinhibitory concentrations of antituberculosis agents. Tuberculosis (Edinb.) 95(2) , 155-61, (2015) Several reports have elaborated on the role of efflux pumps in drug resistance in Mycobacterium tuberculosis by analysing the mRNA expression profiles. However, there is no uniformity in the subinhibi... | |
| Decreased lipogenesis in white adipose tissue contributes to the resistance to high fat diet-induced obesity in phosphatidylethanolamine N-methyltransferase-deficient mice. Biochim. Biophys. Acta 1851(2) , 152-62, (2015) Mice lacking phosphatidylethanolamine N-methyltransferase (PEMT, Pemt(-/-) mice) are resistant to high-fat diet (HFD)-induced obesity (DIO) but develop non-alcoholic steatohepatitis. PEMT expression i... | |
| Exploring the impact of drug properties on the extent of intestinal lymphatic transport - in vitro and in vivo studies. Pharm. Res. 32(5) , 1817-29, (2015) Intestinal lymphatic transport of specific lipophilic drugs offers therapeutic advantages and maximises oral bioavailability. The aims of this study were; to compare intestinal lymphatic transport of ... |
Synonyms
| oleicacidamide-heptaglycolether |
| Oleic Acid |
| adogen73 |
| Amide O |
| OLEAMID |
| Armid O |
| Slip-eze |
| AMD-O |
| octadec-9-enoic acid |
| MFCD00003274 |
| EINECS 200-001-8 |
| cis-9-octadecenamide |
| cis-oleamide |
| cis-9-Octadecenoic acid |
